Personalis NeXT Dx™ Test

Increasingly, oncologists and pathologists are utilizing information on genomic alterations in solid tumors, such as lung, colon, breast, melanoma, and prostate cancers, to help guide and optimize therapeutic options for patients including enrolling into cancer clinical trials. The Personalis NeXT Dx™ Test provides clinicians with a comprehensive and accurate next generation sequencing-based testing solution for solid tumors. This test is not validated for hematolymphoid malignancies or sarcomas.

NeXT Dx Test
Download